1 Day Online Training Course on Effective Defence of EPO (European Patent Office) Patent Applications
February 27, 2024 12:14 ET
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Effective Defence of EPO (European Patent Office) Patent Applications Training Course" has been added to ResearchAndMarkets.com's offering. Clarity...
TransCode Therapeutics Reports Publication of United States Patent Application Covering TransCode’s RIG-I Agonist Immunotherapeutic
February 20, 2024 08:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Reports Publication of United States Patent Application Covering TransCode’s RIG-I Agonist Immunotherapeutic
Advanced Drafting Techniques for Successful EPO (European Patent Office) Patent Applications: 1-Day Online Training Course (May 10th, 2024)
January 31, 2024 05:55 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Advanced Drafting Techniques for Successful EPO (European Patent Office) Patent Applications Training Course" conference has been added to ...
BioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity Program
December 12, 2023 09:15 ET
|
BioRestorative Therapies, Inc
--Notice of allowance will be the fourth U.S. patent granted under Company’s ThermoStem® program targeting obesity and metabolic disorders, including type 2 diabetes-- MELVILLE, N.Y., Dec. 12, 2023 ...
Navigate Added Subject Matter and Disclosure Challenges: Advanced Drafting Techniques for Successful EPO (European Patent Office) Patent Applications Training Course (London, UK - November 10, 2023)
August 16, 2023 08:58 ET
|
Research and Markets
Dublin, Aug. 16, 2023 (GLOBE NEWSWIRE) -- The "Advanced Drafting Techniques for Successful EPO (European Patent Office) Patent Applications Training Course" conference has been added to ...
Effective Defence of EPO (European Patent Office) Patent Applications Training Course (London, United Kingdom - November 9, 2023)
April 18, 2023 13:03 ET
|
Research and Markets
Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "Effective Defence of EPO (European Patent Office) Patent Applications Training Course" conference has been added to ResearchAndMarkets.com's...
Innovation Scorecard for 3,500+ Companies - Identify the Disruptive Potential of the Companies in Your Investment Portfolio
November 23, 2022 04:23 ET
|
Research and Markets
Dublin, Nov. 23, 2022 (GLOBE NEWSWIRE) -- The "Company Innovation Scorecard - Ranking 3,500 Innovative Companies on Activity, Impact and Disruptive Potential of their Intellectual Property (IP)...
Citrine Global Corp. (OTCQB: CTGL) Files Provisional Patent Application for Balancing Side Effects
November 16, 2022 10:10 ET
|
Citrine Global, Corp.
Company also Announces the Introduction of GreenFeelsTM Product Lines Tel Aviv, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Citrine Global Corp. (OTCQB: CTGL) is pleased to announce that the Company’s...
Global Digital Rights Management (DRM) Markets, 2022-2027: Expansion of OTT Platforms & Rise in Corporate Need to Protect Data Present Lucrative Opportunities
August 30, 2022 06:58 ET
|
Research and Markets
Dublin, Aug. 30, 2022 (GLOBE NEWSWIRE) -- The "Digital Rights Management Market by Component (Solutions and Services), Application (Audio Content, Images, Video Content, Confidential Documents,...
OWP Pharmaceuticals Announces Patent Application for the First-Ever Oral Liquid Formulation of Atomoxetine Hydrochloride for the Treatment of Attention Deficit Hyperactivity Disorder
April 22, 2021 08:00 ET
|
OWP Pharmaceuticals
NAPERVILLE, Ill., April 22, 2021 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc. is a privately held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...